{
  "url": "https://struct.news/briefs/cencoras-gross-profit-jumped-24-its-new-debt-is-taking-a-cut",
  "title": "Cencora’s gross profit jumped 24%. Its new debt is taking a cut",
  "summary": "Revenue rose 5.1% in the three months ended June 30, while gross profit grew nearly five times faster.",
  "published_at": "2026-08-05T19:27:47.048239+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Cencora, Inc.",
    "ticker": "COR",
    "cik": "1140859",
    "sector": "Healthcare",
    "industry": "Medical Distribution"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-08-05",
    "accession": "0001140859-26-000034",
    "url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000034/cor-20260630.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-06",
    "url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085925000122/cor-20250630.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 321332819000,
      "display": "$321.3B",
      "unit": "usd",
      "period": "2025-09-30",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-Q",
        "accession": "0001140859-26-000034",
        "filing_date": "2026-08-05"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": 9.312270535076262,
      "display": "+9.3%",
      "unit": "percent",
      "period": "2025-09-30",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001140859-26-000034",
        "filing_date": "2026-08-05"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Operating margin",
      "value": 0.8180306662046867,
      "display": "+0.8%",
      "unit": "percent",
      "period": "2025-09-30",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001140859-26-000034",
        "filing_date": "2026-08-05"
      }
    }
  ],
  "watch_next": [
    {
      "type": "interest_rates",
      "statement": "Debt raised for OneOncology drove a sharp increase in interest expense, making borrowing costs a material part of the earnings comparison.",
      "importance": "medium",
      "evidence": "The increase in interest expense was primarily due to the issuance of our $3.0 billion of senior notes and the $1.5 billion of variable-rate term loans in February 2026",
      "source_date": "2026-08-05"
    }
  ],
  "related_tickers": [
    "COR"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}